Elena Prokupets, Director at C4 Therapeutics, Inc. (CCCC), sold 64,140 shares at $50.10 ($3.2M) on 2021-09-22, disclosed to the SEC on 2021-09-24.
Open-market sale of $3.2M CCCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.09 | 7,004 | $351K | 10.9% |
| 2 | $50.09 | 7,004 | $351K | 10.9% |
| 3 | $50.10 | 3,544 | $178K | 5.5% |
| 4 | $50.10 | 3,544 | $178K | 5.5% |
| 5 | $50.35 | 5,926 | $298K | 9.3% |
| 6 | $50.35 | 5,926 |
| $298K |
| 9.3% |
| 7 | $50.35 | 11,801 | $594K | 18.4% |
| 8 | $50.35 | 11,801 | $594K | 18.4% |
| 9 | $51.08 | 1,007 | $51K | 1.6% |
| 10 | $51.08 | 1,007 | $51K | 1.6% |
| 11 | $51.09 | 446 | $23K | 0.7% |
| 12 | $50.10 | 2,115 | $106K | 3.3% |
| 13 | $50.10 | 2,115 | $106K | 3.3% |
| 14 | $50.11 | 900 | $45K | 1.4% |
| Total | $50.27 avg | 64,140 | $3.2M | 100% |
| Filing → |
| CCCC | SELL | 2021-09-16 | $6.4M | — | Filing → |
| CCCC | SELL | 2021-09-14 | $527K | — | Filing → |
| CCCC | SELL | 2021-08-05 | $1.3M | — | Filing → |